Front & Back Matter.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 1, doi. 10.1159/000525501
- Publication type:
- Article
Works matching IS 16613791 AND DT 2022 AND VI 17 AND IP 3
Results: 16
1
2
PharmaNews.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 346, doi. 10.1159/000525391
- Publication type:
- Article
3
Objective Response to First-Line Treatment as a Predictor of Overall Survival in Metastatic Breast Cancer: A Retrospective Analysis from Two Centers over a 25-Year Period.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 264, doi. 10.1159/000519729
- By:
- Publication type:
- Article
4
Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 330, doi. 10.1159/000519728
- By:
- Publication type:
- Article
5
Staging for Breast Cancer: A Nationwide Survey about Adherence to Guidelines in German Breast Centers.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 316, doi. 10.1159/000521967
- By:
- Publication type:
- Article
6
Validation of the 21-Gene Recurrence Score Assay in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer and 0 to 3 Positive Lymph Nodes: Risk Pattern and Outcomes on a Community Level.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 288, doi. 10.1159/000521096
- By:
- Publication type:
- Article
7
Long-Term Survival Outcomes of Patients with Small (≤1 cm) Node-Negative HER2-Positive Breast Cancer Not Treated with Adjuvant Anti-HER2-Targeted Therapy: A 10-Year Follow-Up Study.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 279, doi. 10.1159/000520793
- By:
- Publication type:
- Article
8
Patient-Reported Outcomes in Free-Flap Breast Reconstructive Surgery over Time (PRO-BREST).
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 272, doi. 10.1159/000519804
- By:
- Publication type:
- Article
9
Multivariable Models Based on Baseline Imaging Features and Clinicopathological Characteristics to Predict Breast Pathologic Response after Neoadjuvant Chemotherapy in Patients with Breast Cancer.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 306, doi. 10.1159/000521638
- By:
- Publication type:
- Article
10
Invasive Lobular Carcinoma Has Worse Outcome Compared with Invasive Ductal Carcinoma in Stage IV Breast Cancer with Bone-Only Metastasis.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 296, doi. 10.1159/000521097
- By:
- Publication type:
- Article
11
Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 249, doi. 10.1159/000519533
- By:
- Publication type:
- Article
12
Nationwide Survey of German Outpatient Gynecologic Oncology Practices during the Coronavirus Disease 2019 Pandemic: Reactions to the First Wave and Future Perspectives.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 257, doi. 10.1159/000518858
- By:
- Publication type:
- Article
13
Cost-Effectiveness Analysis of Abemaciclib plus Fulvestrant versus Placebo plus Fulvestrant in Patients with Hormone Receptor-Positive, ERBB2-Negative Breast Cancer.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 237, doi. 10.1159/000518551
- By:
- Publication type:
- Article
14
Influence of Breast Reduction Surgery on Long-Term Breast Cancer Risk in Austria.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 244, doi. 10.1159/000517816
- By:
- Publication type:
- Article
15
Current Understanding and Management of Plasma Cell Mastitis: Can We Benefit from What We Know?
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 321, doi. 10.1159/000517572
- By:
- Publication type:
- Article
16
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference.
- Published in:
- Breast Care, 2022, v. 17, n. 3, p. 336, doi. 10.1159/000517501
- By:
- Publication type:
- Article